Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
TAK: Takeda Pharmaceutical Company Limited Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
TAK
The Story
TAK
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+7.4% / yr
Operating margin
10.5%
ROIC
2.4%
Financially safe
Adequate
Debt / equity
0.65×
Interest coverage
1.5×
Current ratio
1.14×
Valuation
Unrated
P/E ratio
129.5×
Dividend yield
3.6%
Takeda Pharmaceutical Company Limited
TAK
New York Stock Exchange
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Takeda Pharmaceutical Company Limited
TAK
New York Stock Exchange
·
USD
·
Closed
$17.09
−0.93%
$17.09
−$0.16 (0.93%)
52W Range
69th
pctl
Volume
1.22×
avg
Mkt Cap
54.38B
USD
P/E
129.5
TTM
Div Yield
3.63%
ann
52W Range
69th
pctl
Volume
1.22×
avg
Market Cap
54.38B
USD
P/E Ratio
129.5
TTM
Div Yield
3.63%
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings